Novo Nordisk
NVO
#32
Rank
HK$2.303 T
Marketcap
HK$521.61
Share price
-1.67%
Change (1 day)
-47.53%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2024 (TTM): HK$147.58 Billion

According to Novo Nordisk's latest financial reports the company's current earnings are HK$41.89 Billion. , an increase over its 2023 earnings that were of HK$119.94 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2024

Annual earnings

Year Earnings Change
2024 HK$147.23 B22.75%
2023 HK$119.94 B57.64%
2022 HK$76.08 B5.35%
2021 HK$72.22 B12.47%
2020 HK$64.21 B13.07%
2019 HK$56.79 B-3.35%
2018 HK$58.76 B1.79%
2017 HK$57.72 B4.52%
2016 HK$55.22 B9.42%
2015 HK$50.47 B8.24%
2014 HK$46.63 B3.45%
2013 HK$45.08 B19.02%
2012 HK$37.87 B15.21%
2011 HK$32.87 B17.71%
2010 HK$27.93 B24.78%
2009 HK$22.38 B10.62%
2008 HK$20.23 B55.97%
2007 HK$12.97 B7.07%
2006 HK$12.11 B18.18%
2005 HK$10.25 B11.33%
2004 HK$9.20 B
2002 HK$5.91 B-14.39%
2001 HK$6.90 B-52.82%
2000 HK$14.63 B250%
1999 HK$4.18 B31.21%
1998 HK$3.18 B34.31%
1997 HK$2.37 B11.46%
1996 HK$2.12 B9.03%
1995 HK$1.95 B-3.15%
1994 HK$2.01 B-0.67%
1993 HK$2.02 B45.38%
1992 HK$1.39 B-13.81%
1991 HK$1.61 B37.12%
1990 HK$1.18 B-0.79%
1989 HK$1.19 B26.2%
1988 HK$0.94 B24.97%
1987 HK$0.75 B-0.9%
1986 HK$0.76 B-7.78%
1985 HK$0.82 B24.87%
1984 HK$0.66 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
HK$86.38 B-41.33%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$98.57 B-33.05%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$65.14 Billion-144.24%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$61.73 B-58.07%๐Ÿ‡ซ๐Ÿ‡ท France